3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2/3
1
Status
Terminated
2
Withdrawn
1
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Head & Neck
30
Gynecologic
3
Genitourinary
3
Thoracic
2
Other
2
Dermatologic
2
Sarcoma
1
Other solid neoplasm
1
Gastrointestinal
1
Breast
1
Conditions
Obesity
20
Mucositis
19
Constipation
13
Neoplasms
11
Opioid-Induced Constipation
9
Pain
8
Overweight
6
Head and Neck Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Sexual Dysfunction, Physiological
4
Bronchiolitis Obliterans Syndrome
4
Xerostomia
3
Stomatitis
3
Radiation Injuries
3
Polycystic Ovary Syndrome
3
Endometrial Neoplasms
3
Breast Neoplasms
3
Sedentary Behavior
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Multiple Myeloma
2
Glucose Intolerance
2
Dyspnea
2
Chemotherapy-induced Peripheral Neuropathy
2
Venous Thromboembolism
1
Urinary Incontinence
1
Thyroid Diseases
1
Stomach Ulcer
1
Stomach Neoplasms
1
Interventions
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Oropharyngeal Neoplasms
×
Other
×
Clear all
NCT04648020
2023-05-31
VOICE
Monopar Therapeutics
Phase 2/3
Terminated
190 enrolled
NCT01883908
2019-11-07
GCC1229
University of Maryland, Baltimore
Phase NA
Terminated
4 enrolled
3 charts